当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:124.07亿  总市值:124.07亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年半年度实现净利润2.84亿元,每股收益0.88元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年半年度最新股东权益433587.07万元,未分配利润172850.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年半年度最新总资产548942.20万元,负债115355.13万元。

利润表
报告期2023-06-302023-03-312022-12-312022-09-30
营业总收入1,270,455,870.9686,668,622.182,864,044,617.292,075,274,671.51
营业总成本1,034,950,299.72557,268,271.772,293,396,024.591,641,257,015.03
营业利润312,024,833.1151,342,584.47675,680,194.52514,459,068.48
利润总额307,265,104.31151,993,528.18675,336,082.38516,097,297.03
净利润284,211,629.04139,509,813.51611,974,028.96464,543,504.5
其他综合收益-29,978,428.7398,055.44-30,441,133.612,214,447.36
综合收益总额254,233,200.31139,607,868.95581,532,895.35466,757,951.86
资产负债表
报告期2023-06-302023-03-312022-12-312022-09-30
流动资产合计2,893,908,129.693,224,795,967.123,488,519,972.933,485,200,711.89
非流动资产合计2,595,513,915.322,301,977,619.642,000,475,868.791,657,498,256.06
资产总计5,489,422,045.015,526,773,586.765,488,995,841.725,142,698,967.95
流动负债合计993,177,820.341,086,340,517.71,184,475,189.141,097,751,551.08
非流动负债合计160,373,499.2154,431,804.37156,170,208.19112,627,227.38
负债合计1,153,551,319.541,240,772,322.071,340,645,397.331,210,378,778.46
归属于母公司股东权益合计4,128,038,704.494,157,390,941.284,020,637,920.823,900,795,558.18
股东权益合计4,335,870,725.474,286,001,264.694,148,350,444.393,932,320,189.49
负债和股东权益合计5,489,422,045.015,526,773,586.765,488,995,841.725,142,698,967.95
现金流量表
报告期2023-06-302023-03-312022-12-312022-09-30
经营活动现金流入小计1,230,823,379.21643,402,402.792,973,474,961.871,958,373,149.95
经营活动现金流出小计1,117,243,217.79537,150,622.242,341,045,634.61,764,837,747.71
经营活动产生的现金流量净额113,580,161.42106,251,780.55632,429,327.27193,535,402.24
投资活动现金流入小计3,217,731,811.241,793,270,295.0111,936,571,488.849,754,732,369.18
投资活动现金流出小计3,162,387,397.11,549,642,604.7112,187,746,177.159,771,070,809.56
投资活动产生的现金流量净额55,344,414.14243,627,690.3-251,174,688.31-16,338,440.38
筹资活动现金流入小计6,395,0001,275,00061,158,779.2624,272,000
筹资活动现金流出小计171,273,569.737,186,212.16267,393,099.43232,389,313
筹资活动产生的现金流量净额-164,878,569.73-5,911,212.16-206,234,320.17-208,117,313
汇率变动对现金及现金等价物的影响-2,297,481.26-14,527,686.978,898,527.8332,144,292.63
现金及现金等价物净增加额1,748,524.57329,440,571.72183,918,846.621,223,941.49
期末现金及现金等价物余额932,912,237.991,260,604,285.14931,163,713.42748,468,808.29
最新报告期:2023-09-08
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
兴业证券东楠,孙媛媛,黄翰漾1.802.172.642023-09-08
开源证券蔡明子1.772.252.842023-09-05
中信证券宋硕,陈竹2.102.673.352023-09-05
东吴证券周新明,朱国广1.922.453.092023-09-04
安信证券马帅2.042.683.372023-09-03
TOP↑